Sanofi Reports - Industry Research

Over The Counter Drugs Market

The Over The Counter Drugs Market size is estimated at USD 137.39 billion in 2024, and is expected to reach USD 163.10 billion by 2029, growing at a CAGR of 3.49% during the forecast period (2024-2029).

Insomnia Treatment Market

The Insomnia Treatment Market size is estimated at USD 3.58 billion in 2024, and is expected to reach USD 4.60 billion by 2029, growing at a CAGR of 5.16% during the forecast period (2024-2029).

Middle East And Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market

The Middle East And Africa Glucagon-like Peptide-1 Agonists Market size is estimated at USD 124.32 million in 2024, and is expected to reach USD 175.28 million by 2029, growing at a CAGR of 7.26% during the forecast period (2024-2029).

Middle East And Africa Human Insulin Market

The Middle East And Africa Human Insulin Market size is estimated at USD 1.62 billion in 2024, and is expected to reach USD 1.95 billion by 2029, growing at a CAGR of 3.78% during the forecast period (2024-2029).

Middle East and Africa Diabetes Drugs Market

The Middle East and Africa Diabetes Drugs Market size is estimated at USD 4.57 billion in 2023 and is expected to reach USD 6.10 billion by 2028, growing at a CAGR of 5.97% during the forecast period (2023-2028).

Global Pediatric Vaccines Market

The Global Pediatric Vaccines Market size is estimated at USD 20.29 billion in 2024, and is expected to reach USD 27.60 billion by 2029, growing at a CAGR of 6.34% during the forecast period (2024-2029).

Allergy Treatment Market

The Allergy Treatment Market size is estimated at USD 21.05 billion in 2024, and is expected to reach USD 31.07 billion by 2029, growing at a CAGR of 8.10% during the forecast period (2024-2029).

Paracetamol Market

The Paracetamol Market is expected to register a CAGR of 4.3% over the forecast period.

Generic Drugs Market

The Generic Drugs Market size is estimated at USD 413.60 billion in 2024, and is expected to reach USD 508.79 billion by 2029, growing at a CAGR of 4.23% during the forecast period (2024-2029).

Acute Myeloid Leukemia Market

The Acute Myeloid Leukemia Market size is estimated at USD 1.83 billion in 2024, and is expected to reach USD 2.97 billion by 2029, growing at a CAGR of 10.15% during the forecast period (2024-2029).

North America Human Insulin Drugs Market

The North America Human Insulin Drugs Market size is estimated at USD 11.58 billion in 2024, and is expected to reach USD 14.03 billion by 2029, growing at a CAGR of 3.91% during the forecast period (2024-2029).

Human Insulin Drugs Market

The Human Insulin Drugs Market size is estimated at USD 27.96 billion in 2024, and is expected to reach USD 33.81 billion by 2029, growing at a CAGR of 3.87% during the forecast period (2024-2029).

Asia-Pacific Cancer Vaccines Market

The Asia-Pacific Cancer Vaccines Market size is estimated at USD 2.34 billion in 2024, and is expected to reach USD 4.06 billion by 2029, growing at a CAGR of 11.55% during the forecast period (2024-2029).

Orthobiologics Market

The Orthobiologics Market size is estimated at USD 6.28 billion in 2024, and is expected to reach USD 9.14 billion by 2029, growing at a CAGR of 6.30% during the forecast period (2024-2029).

North America Biguanide Market

The North America Biguanide Market size is estimated at USD 1.36 billion in 2024, and is expected to reach USD 1.58 billion by 2029, growing at a CAGR of 2.59% during the forecast period (2024-2029).

Europe Insulin Delivery Devices Market

The Europe Insulin Delivery Devices Market size is estimated at USD 2.83 billion in 2024, and is expected to reach USD 3.12 billion by 2029, growing at a CAGR of 1.9% during the forecast period (2024-2029).

Insulin Pens Market

The Insulin Pens Market size is estimated at USD 33.31 billion in 2024, and is expected to reach USD 39.36 billion by 2029, growing at a CAGR of 3.40% during the forecast period (2024-2029).

Topical Analgesic Market

The topical analgesic market size is expected to grow from USD 4.58 billion in 2023 to USD 6.26 billion by 2028, registering a CAGR of 6.44% during the forecast period.

Human Insulin Drugs And Delivery Devices Market

The Human Insulin Drugs And Delivery Devices Market size is estimated at USD 67.45 billion in 2024, and is expected to reach USD 80.99 billion by 2029, growing at a CAGR of 3.73% during the forecast period (2024-2029).

Pharmaceutical Intermediates Market

The Pharmaceutical Intermediates Market size is estimated at USD 42.31 billion in 2024, and is expected to reach USD 60.52 billion by 2029, growing at a CAGR of 7.42% during the forecast period (2024-2029).

Influenza Vaccine Market

The Influenza Vaccine Market is expected to register a CAGR of 5.65% during the forecast period.

Pharmaceutical Manufacturing Market

The Pharmaceutical Manufacturing Market size is estimated at USD 465.16 billion in 2024, and is expected to reach USD 967.12 billion by 2029, growing at a CAGR of 12.14% during the forecast period (2024-2029).

Germany OTC Drug Market

The Germany OTC Drug Market size is estimated at USD 9.11 billion in 2024, and is expected to reach USD 11.19 billion by 2029, growing at a CAGR of 4.23% during the forecast period (2024-2029).

US Diabetes Care Drugs Market

The US Diabetes Care Drugs Market size is estimated at USD 32.59 billion in 2024, and is expected to reach USD 39.08 billion by 2029, growing at a CAGR of 3.70% during the forecast period (2024-2029).

Thailand Diabetes Care Drugs Market

The Thailand Diabetes Care Drugs Market size is estimated at USD 152.23 million in 2024, and is expected to reach USD 173.23 million by 2029, growing at a CAGR of 3.80% during the forecast period (2024-2029).

Philippines Diabetes Care Drugs Market

The Philippines Diabetes Care Drugs Market size is estimated at USD 264.24 million in 2024, and is expected to reach USD 319.95 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029).

South Korea Diabetes Drugs Market

The South Korea Diabetes Drugs Market size is estimated at USD 1 billion in 2024, and is expected to reach USD 1.22 billion by 2029, growing at a CAGR of 4.04% during the forecast period (2024-2029).

Iran Diabetes Care Drugs Market

The Iran Diabetes Care Drugs Market size is estimated at USD 331.92 million in 2024, and is expected to reach USD 401.90 million by 2029, growing at a CAGR of 3.9% during the forecast period (2024-2029).

Japan Diabetes Drugs Market

The Japan Diabetes Drugs Market size is estimated at USD 3.15 billion in 2024, and is expected to reach USD 4.03 billion by 2029, growing at a CAGR of 4.98% during the forecast period (2024-2029).

Asia-Pacific Insulin Pens Market

The Asia-Pacific Insulin Pens Market size is estimated at USD 17.46 billion in 2024, and is expected to reach USD 20.03 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).

United States Insulin Drugs And Delivery Devices Market

The United States Insulin Drugs And Delivery Devices Market size is estimated at USD 19.70 billion in 2024, and is expected to reach USD 22.5 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).

France Insulin Drugs And Delivery Devices Market

The France Insulin Drugs And Delivery Devices Market size is estimated at USD 736.48 million in 2024, and is expected to reach USD 789.49 million by 2029, growing at a CAGR of 1.40% during the forecast period (2024-2029).

UK Insulin Drugs And Delivery Devices Market

The UK Insulin Drugs And Delivery Devices Market size is estimated at USD 499.83 million in 2024, and is expected to reach USD 549.15 million by 2029, growing at a CAGR of 1.9% during the forecast period (2024-2029).

Canada Insulin Drugs And Delivery Devices Market

The Canada Insulin Drugs And Delivery Devices Market size is estimated at USD 1.68 billion in 2024, and is expected to reach USD 1.83 billion by 2029, growing at a CAGR of 1.7% during the forecast period (2024-2029).

Japan Insulin Drugs And Delivery Devices Market

The Japan Insulin Drugs And Delivery Devices Market size is estimated at USD 8.5 billion in 2024, and is expected to reach USD 9.57 billion by 2029, growing at a CAGR of 2.40% during the forecast period (2024-2029).

Japan Oral Anti-Diabetic Drug Market

The Japan Oral Anti-Diabetic Drug Market size is estimated at USD 2.42 billion in 2024, and is expected to reach USD 3.02 billion by 2029, growing at a CAGR of 4.60% during the forecast period (2024-2029).

Italy Oral Anti-Diabetic Drug Market

The Italy Oral Anti-Diabetic Drug Market size is estimated at USD 705.48 million in 2024, and is expected to reach USD 837.88 million by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).

India Oral Anti-Diabetic Drug Market

The India Oral Anti-Diabetic Drug Market size is estimated at USD 1.7 billion in 2024, and is expected to reach USD 2.01 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).

New Zealand Oral Anti-Diabetic Drug Market

The New Zealand Oral Anti-Diabetic Drug Market size is estimated at USD 323 million in 2024, and is expected to reach USD 367.23 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029).

North America Oral Anti-Diabetic Drug Market

The North America Oral Anti-Diabetic Drug Market size is estimated at USD 18.76 billion in 2024, and is expected to reach USD 23.60 billion by 2029, growing at a CAGR of 4.70% during the forecast period (2024-2029).

Europe Oral Anti-Diabetic Drug Market

The Europe Oral Anti-Diabetic Drug Market size is estimated at USD 7.36 billion in 2024, and is expected to reach USD 8.70 billion by 2029, growing at a CAGR of 3.40% during the forecast period (2024-2029).

Asia-Pacific Oral Anti-Diabetic Drug Market

The Asia-Pacific Oral Anti-Diabetic Drug Market size is estimated at USD 25.37 billion in 2024, and is expected to reach USD 29.56 billion by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).

Mexico Oral Anti-Diabetic Drug Market

Mexico's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period, with revenue of USD 1.5 billion in the current year.

Brazil Oral Anti-Diabetic Drug Market

The Brazil Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period, with revenue of USD 861 million in the current year.

Malaysia Oral Anti-Diabetic Drug Market

The Malaysia Oral Anti-Diabetic Drug Market is expected to register a CAGR of over 3% during the forecast period.

India Insulin Drug And Delivery Device Market

India's Insulin Drug and Delivery Device Market is expected to register a CAGR of more than 1% and reach a value of about USD 2.4 billion over the forecast period.

Vietnam Insulin Drug And Delivery Device Market

Vietnam's Insulin Drug and Delivery Device Market is expected to register a CAGR of more than 2% and reach a value of about USD 483 million over the forecast period.

China Insulin Drugs And Delivery Devices Market

The China Insulin Drugs and Delivery Devices Market is expected to register a CAGR of 2.6% and reach a value of about USD 8.7 billion over the forecast period.

South Korea Oral Anti-Diabetic Drug Market

South Korea Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period and 506 million in revenue in the forecast period.

France Oral Anti-Diabetic Drug Market

France's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period and revenue of USD 0.7 billion in the current year.

Vietnam Oral Anti-Diabetic Drug Market

The Vietnam Oral Anti-Diabetic Drug Market size is estimated at USD 156.21 million in 2024, and is expected to reach USD 195.32 million by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).

Indonesia Oral Anti-Diabetic Drug Market

The Indonesia Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 4% during the forecast period and USD 202 million in revenue in the current year.

Philippines Oral Anti-Diabetic Drug Market

The Philippines Oral Anti-Diabetic Drug Market size is estimated at USD 202.20 million in 2024, and is expected to reach USD 251.32 million by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).

Brazil Oral Anti-Diabetic Drug Market

The Brazil Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 3% during the forecast period, with revenue of USD 13 billion in the current year.

Thailand Oral Antidiabetic Drug Market

Thailand's Oral Anti-Diabetic Drug Market is expected to register a CAGR of more than 6% during the forecast period and 68 million in revenue in the current year.

South Africa Oral Antidiabetic Drug Market

The South Africa Oral Antidiabetic Drug Market size is estimated at USD 241.78 million in 2024, and is expected to reach USD 275.36 million by 2029, growing at a CAGR of greater than 2% during the forecast period (2024-2029).

South Korea Insulin Drugs And Delivery Devices Market

The South Korea Insulin Drugs And Delivery Devices Market size is estimated at USD 756.38 million in 2024, and is expected to reach USD 849.04 million by 2029, growing at a CAGR of 2.34% during the forecast period (2024-2029).

Latin America Insulin Pens Market

The Latin America Insulin Pens Market size is estimated at USD 0.4 billion in 2024, and is expected to reach USD 0.52 billion by 2029, growing at a CAGR of greater than 1.8% during the forecast period (2024-2029).

US Diabetes Drugs And Devices Market

The US Diabetes Drugs And Devices Market size is estimated at USD 60.12 billion in 2024, and is expected to reach USD 70.24 billion by 2029, growing at a CAGR of greater than 4% during the forecast period (2024-2029).

South Africa Diabetes Drugs and Devices Market

South Africa's diabetes care drugs and devices market size was estimated at USD 0.47 billion in the current year.

Russia Diabetes Drugs and Devices Market

Russian diabetes drugs and devices market is estimated at USD 2.2 billion in the current year.

India Diabetes Drugs and Devices Market

India's diabetes care drugs and devices market size is estimated at USD 3.8 billion in the current year.

Australia Diabetes Drugs and Devices Market

The Australian diabetes drugs and devices market size is estimated at USD 1.4 billion in the current year.

South Korea Diabetes Drugs and Devices Market

South Korea's diabetes drugs and devices market size is estimated at USD 1.4 billion in the current year.

Vietnam Diabetes Drugs and Devices Market

Vietnam's diabetes drugs and devices market size is estimated at USD 0.6 billion in the current year.

Spain Diabetes Drugs and Devices Market

Spain's diabetes drugs and devices market is estimated at USD 0.7 billion in the current year.

Germany Diabetes Drugs and Devices Market

Germany's diabetes drugs and devices market size is estimated at USD 6 billion in the current year.

Egypt Diabetes Drugs and Devices Market

Egypt's diabetes drugs and devices market size is estimated at USD 0.7 billion in the current year.

Mexico Diabetes Drugs and Devices Market

Mexico's diabetes drugs and devices market size is estimated at USD 2.4 billion in the current year.

China Diabetes Drugs And Devices Market

The China Diabetes Drugs And Devices Market size is estimated at USD 19.66 billion in 2024, and is expected to reach USD 22.77 billion by 2029, growing at a CAGR of greater than 3.5% during the forecast period (2024-2029).

Japan Diabetes Drugs And Devices Market

The Japan Diabetes Drugs And Devices Market size is estimated at USD 4.80 billion in 2024, and is expected to reach USD 6.40 billion by 2029, growing at a CAGR of greater than 3.20% during the forecast period (2024-2029).

Thailand Diabetes Drugs And Devices Market

The Thailand Diabetes Drugs And Devices Market size is estimated at USD 0.28 billion in 2024, and is expected to reach USD 0.35 billion by 2029, growing at a CAGR of greater than 5.02% during the forecast period (2024-2029).

Philippines Diabetes Drugs and Devices Market

Philippines diabetes drugs and devices market size is estimated at USD 0.3 billion in the current year.

Oman Diabetes Drugs And Devices Market

The Oman Diabetes Drugs And Devices Market size is estimated at USD 199.07 million in 2024, and is expected to reach USD 274.19 million by 2029, growing at a CAGR of greater than 5% during the forecast period (2024-2029).

Iran Diabetes Drugs and Devices Market

Iran's diabetes drugs and devices market size is estimated at USD 1 billion in the current year.

Injectable Anti-diabetic Drugs Market

The Injectable Anti-diabetic Drugs Market size is estimated at USD 38.79 billion in 2024, and is expected to reach USD 45.10 billion by 2029, growing at a CAGR of greater than 3% during the forecast period (2024-2029).

Expectorant Drugs Market

The Expectorant Drugs Market size is estimated at USD 100 million in 2024, and is expected to reach USD 120 million by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).

South America Dietary Supplement Market

South America Dietary Supplement market is projected to grow at a CAGR of 7.7% during the forecast period (2020 - 2025).

Antidepressant Market

The antidepressant market is expected to register a CAGR of 3.5% over the forecast period.

Prostate Cancer Diagnostics and Therapy Market

The prostate cancer diagnostics and therapy market was expected to register a CAGR of nearly 13.7% during the forecast period.

Europe Clinical Trials Market

The European clinical trials market is expected to register a CAGR of 4.2% over the forecast period.

Spain Over-the-counter (OTC) Drugs Market

The Spain over-the-counter (OTC) drugs market registered a CAGR of nearly 5.4% over the forecast period, 2022-2027.

Europe Insulin Drugs Market

The Europe Insulin Drugs Market size is estimated at USD 5.95 billion in 2024, and is expected to reach USD 7.55 billion by 2029, growing at a CAGR of 4.89% during the forecast period (2024-2029).

Asia-Pacific Over-the-counter (OTC) Drugs Market

The growth propelling factors of the Asia-Pacific over-the-counter (OTC) drugs market are product innovations, high penetration in emerging countries, like India and China, and the inclination of pharmaceutical companies toward OTC drugs over prescription drugs.

Diabetes Care Drugs Market

The Diabetes Care Drugs Market size is estimated at USD 87.53 billion in 2024, and is expected to reach USD 104.01 billion by 2029, growing at a CAGR of 3.51% during the forecast period (2024-2029).

Insulin Delivery Devices Market

The Insulin Delivery Devices Market size is estimated at USD 39.57 billion in 2024, and is expected to reach USD 47.17 billion by 2029, growing at a CAGR of 3.57% during the forecast period (2024-2029).

Osteoarthritis Treatment Market

The Osteoarthritis Treatment Market size is estimated at USD 7.33 billion in 2024, and is expected to reach USD 9.24 billion by 2029, growing at a CAGR of 4.74% during the forecast period (2024-2029).

Antacids Market

The Global Antacids Market size is expected to grow from USD 6,810.11 million in 2023 to USD 8,194.33 million by 2028, registering a CAGR of 3.7% during the forecast period (2023-2028).

Global Rabies Vaccine Market

The rabies vaccine market is expected to register a CAGR of 5.1% over the forecast period.

Europe Diabetes Drugs Market

The Europe Diabetes Drugs Market size is estimated at USD 16.43 billion in 2024, and is expected to reach USD 20.23 billion by 2029, growing at a CAGR of 4.25% during the forecast period (2024-2029).

Oral Anti-Diabetic Drugs Market

The Oral Anti-Diabetic Drugs Market size is estimated at USD 46.82 billion in 2024, and is expected to reach USD 57.44 billion by 2029, growing at a CAGR of 4.17% during the forecast period (2024-2029).

Basal Insulin Market

The Basal Insulin Market size is estimated at USD 273.68 million in 2024, and is expected to reach USD 344.33 million by 2029, growing at a CAGR of 4.70% during the forecast period (2024-2029).

Ear Infection Treatment Market

The Ear Infection Treatment Market size is estimated at USD 12.23 billion in 2024, and is expected to reach USD 15.09 billion by 2029, growing at a CAGR of 4.29% during the forecast period (2024-2029).

Global Bronchitis Treatment Market

The bronchitis treatment market is expected to grow at a CAGR of 3.6% over the forecast period (2022-2027).

Global Constipation Treatment Market

The constipation treatment market is expected to register a CAGR of nearly 6.9% during the forecast period of 2022-2027.

Dysmenorrhea Treatment Market

The dysmenorrhea treatment market is expected to register a CAGR of 8.1% during the forecast period.

Tetanus Toxoid Vaccine Market

The tetanus toxoid vaccine market is expected to register a CAGR of 4.8% during the forecast period.

Global Viscosupplementation Market

The viscosupplementation market is projected to grow with a CAGR of 5.8% during the forecast period (2022 - 2027).

Intravenous Iron Drugs Market

The intravenous iron drugs market is expected to grow at a significant CAGR of 8.35% during the forecast period.

New Zealand Insulin Drugs and Devices Market

The New Zealand Insulin Drugs and Devices Market size is estimated at USD 523.18 million in 2024, and is expected to reach USD 552.60 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029).

New Zealand Diabetes Drugs Market

The New Zealand Diabetes Drugs Market size is estimated at USD 717.24 million in 2024, and is expected to reach USD 872.63 million by 2029, growing at a CAGR of 4% during the forecast period (2024-2029).

New Zealand Diabetes Devices Market

The New Zealand Diabetes Devices Market size is estimated at USD 435.36 million in 2024, and is expected to reach USD 512.09 million by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029).

Omega-3 Products Market

The Omega-3 Products Market size is estimated at USD 47.77 billion in 2024, and is expected to reach USD 68.86 billion by 2029, growing at a CAGR of 7.59% during the forecast period (2024-2029).

India Drug Delivery Devices Market

The India Drug Delivery Devices Market is poised at a CAGR of nearly 5.5% during the forecast period (2022-2027).

Brazil Drug Delivery Devices Market

The Brazil drug delivery devices market is expected to register a CAGR of 4.5% over the forecast period.

North America Over the Counter Drugs Market

The North America Over the Counter (OTC) Drugs Market is anticipated to grow with a CAGR of 2.7%, during the forecast period.

Global Leukemia Therapeutics Market

The Leukemia Therapeutics Market is expected to register a CAGR of 5.5% over the forecast period.

Healthcare Nanotechnology (Nanomedicine) Market

The healthcare nanotechnology (nanomedicine) market is expected to register a CAGR of nearly 11.9% during the forecast period.

Global Cytokine Market

The cytokine market is expected to register a CAGR of 6.2% during the forecast period (2022-2027).

North America Diabetes Drugs Market

The North America Diabetes Drugs Market size is estimated at USD 35.82 billion in 2024, and is expected to reach USD 42.36 billion by 2029, growing at a CAGR of 3.58% during the forecast period (2024-2029).

Spain Diabetes Devices Market

The Spain Diabetes Devices Market size is estimated at USD 0.71 billion in 2024, and is expected to reach USD 1.02 billion by 2029, growing at a CAGR of 7.41% during the forecast period (2024-2029).

Asia - Pacific Human Insulin Market

The Asia - Pacific Human Insulin Market size is estimated at USD 7.29 billion in 2023, and is expected to reach USD 8.27 billion by 2028, growing at a CAGR of 2.54% during the forecast period (2023-2028).

Iron Deficiency Anemia Therapy Market

The Iron Deficiency Anemia Therapy Market size is estimated at USD 3.69 billion in 2024, and is expected to reach USD 4.84 billion by 2029, growing at a CAGR of 5.60% during the forecast period (2024-2029).

Global Recombinant DNA (rDNA) Technology Market

The recombinant DNA (rDNA) technology market is projected to register a CAGR of 6.8% during the forecast period (2022-2027).

Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Market

The Asia-Pacific Glucagon-like Peptide-1 Agonists Market size is estimated at USD 0.9 billion in 2024, and is expected to reach USD 1.17 billion by 2029, growing at a CAGR of 5.38% during the forecast period (2024-2029).

Europe Glucagon-Like Peptide-1 (GLP-1) Agonists Market

The Europe Glucagon-Like Peptide-1 Agonists Market size is estimated at USD 3.94 billion in 2024, and is expected to reach USD 5.25 billion by 2029, growing at a CAGR of 5.90% during the forecast period (2024-2029).

North America Glucagon-like Peptide-1 Agonists Market

The North America Glucagon-like Peptide-1 Agonists Market size is estimated at USD 6.94 billion in 2024, and is expected to decline to USD 6.68 billion by 2029.

Glucagon-like Peptide-1 (GLP-1) Agonists Market

The Glucagon-like Peptide-1 Agonists Market size is estimated at USD 11.99 billion in 2024, and is expected to reach USD 12.63 billion by 2029, growing at a CAGR of 1.12% during the forecast period (2024-2029).

Asia-Pacific Diabetes Care Drugs Market

The Asia-Pacific Diabetes Care Drugs Market size is estimated at USD 24.99 billion in 2024, and is expected to reach USD 28.70 billion by 2029, growing at a CAGR of 2.81% during the forecast period (2024-2029).

Latin America Diabetes Care Drugs Market

The Latin America Diabetes Care Drugs Market size is estimated at USD 4.71 billion in 2024, and is expected to reach USD 5.58 billion by 2029, growing at a CAGR of 3.48% during the forecast period (2024-2029).

Sulfonylureas Market

The Sulfonylureas Market size is estimated at USD 9.98 billion in 2024, and is expected to reach USD 11.32 billion by 2029, growing at a CAGR of 3.12% during the forecast period (2024-2029).

Non-opioid Pain Patch Market

The non-opioid pain patch market is expected to register a CAGR of 3.0% during the forecast period.

Thrombosis Drugs Market

The thrombosis drugs market is expected to register a CAGR of about 9.0% over the forecast period.

MEA Insulin Pens Market

The MEA Insulin Pens Market size is estimated at USD 1.02 billion in 2024, and is expected to reach USD 1.13 billion by 2029, growing at a CAGR of 2.19% during the forecast period (2024-2029).

Europe Insulin Pens Market

The Europe Insulin Pens Market size is estimated at USD 2.13 billion in 2023 and is expected to reach USD 2.29 billion by 2028, growing at a CAGR of 1.45% during the forecast period (2023-2028).

Mergers And Acquisitions In The Diabetes Market

The Mergers And Acquisitions In The Diabetes Market size is estimated at USD 85.73 billion in 2024, and is expected to reach USD 102.76 billion by 2029, growing at a CAGR of 3.69% during the forecast period (2024-2029).

Meningococcal Vaccines Market

The meningococcal vaccines market is expected to register a CAGR of around 9.5% over the forecast period.

Canada Diabetes Care Drugs And Devices Market

The Canada Diabetes Care Drugs And Devices Market size is estimated at USD 5.40 billion in 2024, and is expected to reach USD 7.04 billion by 2029, growing at a CAGR of 4.75% during the forecast period (2024-2029).

Global Artemisinin Combination Therapy Market

Over the next few years, the market for artemisinin combination therapy is expected to grow at a CAGR of 8.31%.

Multiple Sclerosis Therapeutics Market

The Multiple Sclerosis Therapeutics Market size is estimated at USD 29.65 billion in 2024, and is expected to reach USD 35.16 billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029).

Liver Diseases Therapeutics Market

During the forecast period, the market for medicines to treat liver disease is expected to register a CAGR of about 8.5%.

Sarcopenia Treatment Market

The Sarcopenia Treatment Market size is estimated at USD 3.07 billion in 2024, and is expected to reach USD 4.02 billion by 2029, growing at a CAGR of 4.48% during the forecast period (2024-2029).

Global Rare Hemophilia Factors Market

The rare hemophilia factors market is expected to record a CAGR of 4.3% over the forecast period (2022-2027).

Global Joint Pain Injections Market

Joint Pain Injections Market is expected to register a growth at a CAGR of 6% over the forecast period.

.

Global Hypertrophic Cardiomyopathy Therapeutics Market

The Hypertrophic Cardiomyopathy Therapeutics Market is expected to grow at a CAGR of 1.8% over the forecast period (2022-2027).

Nasal Polyps Treatment Market

The Nasal Polyps Treatment Market is anticipated to witness a CAGR of nearly 6.2% during the forecast period.

Global Hereditary Angioedema Therapeutics Market

The hereditary angioedema therapeutics market is expected to register a CAGR of 8.5% during the forecast period.

Lysosomal Storage Disease Treatment Market

The lysosomal storage disease treatment market is expected to register a CAGR of 8.2% during the forecast period.

Global Hyperlipidemia Drugs Market

The hyperlipidemia drugs market is expected to register a CAGR of 2.3% during the forecast period.

Iceland Pharmaceutical Market

The Iceland Pharmaceutical market studied was anticipated to show a low growth with a CAGR of 2.8%, during the forecast period (2022-2027).

Pompe Disease Market

The Pompe disease market is expected to register a CAGR of 4.5% over the forecast period.

Anemia Treatment Market

Over the next few years, the anemia treatment market is expected to register a CAGR of 7.3%.

Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market

The Europe Insulin Drugs And Glucagon-Like Peptide 1 Receptor Agonist Market size is estimated at USD 9.62 billion in 2024, and is expected to reach USD 12.05 billion by 2029, growing at a CAGR of 4.61% during the forecast period (2024-2029).

Global Diagnostics Enzyme

The diagnostics enzyme market is expected to register a CAGR of 6.2% during the forecast period of 2021-2026.

Penicillin Drug Market

The Penicillin Drug Market size is estimated at USD 10.71 billion in 2024, and is expected to reach USD 12.55 billion by 2029, growing at a CAGR of 3.21% during the forecast period (2024-2029).

High Potency APIs /HPAPI Market

The High Potency APIs /HPAPI Market size is estimated at USD 26.85 billion in 2024, and is expected to reach USD 41.83 billion by 2029, growing at a CAGR of 9.27% during the forecast period (2024-2029).

Global Fibrate Drugs Market

The fibrate drugs market is projected to register a CAGR of 5.2% during the forecast period.

Egypt Diabetes Drugs Market

The Egypt Diabetes Drugs Market size is estimated at USD 414.66 million in 2024, and is expected to reach USD 480.70 million by 2029, growing at a CAGR of 3% during the forecast period (2024-2029).

Saudi Arabia Diabetes Drugs Market

The Saudi Arabia Diabetes Drugs Market size is estimated at USD 1.87 billion in 2024, and is expected to reach USD 2.89 billion by 2029, growing at a CAGR of 9% during the forecast period (2024-2029).

Mexico Diabetes Drugs Market

The Mexico Diabetes Drugs Market size is estimated at USD 2.04 billion in 2024, and is expected to reach USD 2.39 billion by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029).

Vietnam Diabetes Care Drugs Market

The Vietnam Diabetes Care Drugs Market size is estimated at USD 208.45 million in 2024, and is expected to reach USD 249.97 million by 2029, growing at a CAGR of 3.70% during the forecast period (2024-2029).

India Diabetes Care Drugs Market

The India Diabetes Care Drugs Market size is estimated at USD 1.7 billion in 2024, and is expected to reach USD 2.01 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).

Russia Diabetes Drugs Market

The Russia Diabetes Drugs Market size is estimated at USD 1.04 billion in 2024, and is expected to reach USD 1.31 billion by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).

Europe Omega-3 Products Market

The European omega-3 products market is projected to reach a CAGR of 7.00% over the next five years.

Human Recombinant Insulin Market

The Human Recombinant Insulin Market size is estimated at USD 28.47 billion in 2024, and is expected to reach USD 32.20 billion by 2029, growing at a CAGR of greater than 2.9% during the forecast period (2024-2029).

Biguanides Market

The Biguanides Market size is estimated at USD 5.20 billion in 2024, and is expected to reach USD 5.76 billion by 2029, growing at a CAGR of 2.07% during the forecast period (2024-2029).

Combination Anti-Diabetes Drugs Market

The Combination Anti-Diabetes Drugs Market size is estimated at USD 1.09 billion in 2024, and is expected to reach USD 1.85 billion by 2029, growing at a CAGR of 10.87% during the forecast period (2024-2029).

North America Insulin Delivery Devices Market

The North America Insulin Delivery Devices Market size is estimated at USD 14.59 million in 2024, and is expected to reach USD 18.91 million by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029).

North America Insulin Pens Market

The North America Insulin Pens Market size is estimated at USD 11.99 billion in 2024, and is expected to reach USD 14.87 billion by 2029, growing at a CAGR of 4.87% during the forecast period (2024-2029).

Global Cholera Vaccines Market

The cholera vaccines market is poised to grow at a CAGR of 9.8% over the forecast period.

Australia And New Zealand Diabetes Devices Market

The Australia And New Zealand Diabetes Devices Market size is estimated at USD 1.14 billion in 2024, and is expected to reach USD 1.30 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).

Psoriatic Arthritis Therapeutics Market

The psoriatic arthritis therapeutic market is expected to register a CAGR of 6.65% over the forecast period.

Hyperkalemia Treatment Market

The hyperkalemia treatment market is poised to register a CAGR of 16.79% over the forecast period.

Global Hematologic Malignancies Treatment Market

The Global Hematologic Malignancies Treatment Market size is estimated at USD 67.23 billion in 2024, and is expected to reach USD 97.73 billion by 2029, growing at a CAGR of 7.77% during the forecast period (2024-2029).

Global Immunosuppressant Drugs Market

The immunosuppressant drugs market is expected to register a CAGR of 4.6% during the forecast period.

Influenza Medications Market

Influenza has been recognised as a crucial cause of morbidity and mortality in the human population, which is leading to the development of novel drugs that are intended for reducing consequent health and economic impacts.

Hemoglobinopathies Treatment Market

The global hemoglobinopathies treatment market was studied and projected to grow with a CAGR of nearly 7% over the forecast period.

Blood Disorder Therapeutics Market

The Blood Disorder Therapeutics Market is expected to register a CAGR of 6.2% during the forecast period.

Meperidine Drugs Market

The global meperidine drugs market size is expected to grow at a CAGR of 4.1% over the forecast period.

Thyroid Cancer Therapeutics Market

The thyroid cancer therapeutics market is expected to register a CAGR of 12.4% during the forecast period.

Castrate Resistant Prostate Cancer Therapeutics Market

The Castrate Resistant Prostate Cancer Therapeutics Market is expected to register a CAGR of 6.5% during the forecast period.

Short-acting Insulin Market

The Short-acting Insulin Market size is estimated at USD 7.23 billion in 2024, and is expected to reach USD 8.58 billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029).

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market

The market for non-steroidal anti-inflammatory drugs (NSAIDs) is expected to register a CAGR of 5.2% over the forecast period.

.

Graft Versus Host Disease Treatment Market

The Graft Versus Host disease treatment market is projected to register a CAGR of 8.4% during the forecast period.

Multiple Myeloma Market

The multiple myeloma market is expected to witness a CAGR of 6% over the forecast period.

Global Ethical Pharmaceuticals Market

The Ethical Pharmaceuticals Market is expected to register a CAGR of 10.5% during the forecast period (2022-2027).

Insulin Glargine Market

The Insulin Glargine Market size is estimated at USD 1.54 billion in 2024, and is expected to reach USD 2.09 billion by 2029, growing at a CAGR of 6.28% during the forecast period (2024-2029).

Oman Diabetes Drugs Market

The Oman Diabetes Drugs Market size is estimated at USD 212.26 million in 2024, and is expected to reach USD 292.31 million by 2029, growing at a CAGR of 6.61% during the forecast period (2024-2029).

South Africa Diabetes Drugs Market

The South Africa Diabetes Drugs Market size is estimated at USD 340.72 million in 2024, and is expected to reach USD 384.74 million by 2029, growing at a CAGR of 2.46% during the forecast period (2024-2029).

Indonesia Diabetes Care Drugs Market

The Indonesia Diabetes Care Drugs Market size is estimated at USD 301.55 million in 2024, and is expected to reach USD 370.43 million by 2029, growing at a CAGR of 4.20% during the forecast period (2024-2029).

Malaysia Diabetes Care Drugs Market

The Malaysia Diabetes Care Drugs Market size is estimated at USD 389.13 million in 2024, and is expected to reach USD 423.21 million by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).

China Diabetes Care Drugs Market

The China Diabetes Care Drugs Market size is estimated at USD 12.34 billion in 2024, and is expected to reach USD 14.10 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029).

Latin America Oral Anti-Diabetic Drug Market

The Latin America Oral Anti-Diabetic Drug Market size is estimated at USD 3.25 billion in 2024, and is expected to reach USD 3.86 billion by 2029, growing at a CAGR of 3.5% during the forecast period (2024-2029).

Skin Cancer Therapeutics Market

The Skin Cancer Therapeutics Market is poised to grow at a CAGR of 10.1% over the forecast period.

Europe Novel Drug Delivery System (NDDS) Market

European novel drug delivery system market primarily driven by technological advancements promoting the development of NDDS and the rising need for controlled release of drugs.

Europe Biguanide Market

The Europe Biguanide Market size is estimated at USD 1.25 billion in 2024, and is expected to reach USD 1.33 billion by 2029, growing at a CAGR of 1.27% during the forecast period (2024-2029).

Middle East and Africa Biguanide Market

The Middle East and Africa Biguanide Market size is estimated at USD 311.96 million in 2024, and is expected to reach USD 370.86 million by 2029, growing at a CAGR of 3.52% during the forecast period (2024-2029).

Asia-Pacific Insulin Delivery Devices Market

The Asia-Pacific Insulin Delivery Devices Market size is estimated at USD 18.88 billion in 2024, and is expected to reach USD 21.55 billion by 2029, growing at a CAGR of greater than 2.68% during the forecast period (2024-2029).

Middle East and Africa Insulin Delivery Devices Market

The Middle East and Africa Insulin Delivery Devices Market size is estimated at USD 1.96 billion in 2024, and is expected to reach USD 2.27 billion by 2029, growing at a CAGR of 2.99% during the forecast period (2024-2029).

Organ Transplant Immunosuppressant Drugs Market

The organ transplant immunosuppressant drugs market is expected to register a CAGR of 3.5% during the forecast period.

H1N1 Vaccines Market

The H1N1 Vaccines Market is expected to register a CAGR of 5.2% during the forecast period.

PAP and Paracetamol Market

The PAP and Paracetamol Market is expected to register a CAGR of 4.3% during the forecast period.

Montelukast Sodium Market

The Montelukast Sodium Market size is estimated at USD 4.08 billion in 2024, and is expected to reach USD 7.38 billion by 2029, growing at a CAGR of 12.60% during the forecast period (2024-2029).

Cardiac Arrhythmia Therapeutics Market

The Cardiac Arrhythmia Therapeutics Market is expected to register a CAGR of 4.3% during the forecast period.

Uropathy Treatment Market

The Uropathy Treatment Market is expected to register a CAGR of 4.2% during the forecast period.

Hyaluronic Acid Raw Material Market

The hyaluronic acid raw material market is expected to witness a CAGR of 6.5% during the forecast period.

Hydroxychloroquine Drugs Market

The global hydroxychloroquine drugs market studied was anticipated to register a CAGR of nearly 16.8% during the forecast period.

Pruritus Therapeutics Market

The pruritus therapeutics market is expected to grow at a CAGR of 3.5% during the forecast period.

Global Neurology Clinical Trials Market

The neurology clinical trials market is expected to register a CAGR of 4.35% during the forecast period (2022-2027).

Microneedle Flu Vaccine Market

The Microneedle Flu Vaccine Market size is estimated at USD 1.52 billion in 2024, and is expected to reach USD 2.13 billion by 2029, growing at a CAGR of 6.95% during the forecast period (2024-2029).

Global Acute Otitis Media Treatment Market

The acute otitis media treatment market is expected to register a CAGR of 5.5% during the forecast period, 2022-2027.

Germany Diabetes Drugs Market

The Germany Diabetes Drugs Market size is estimated at USD 4.06 billion in 2024, and is expected to reach USD 4.81 billion by 2029, growing at a CAGR of 3.47% during the forecast period (2024-2029).

Italy Diabetes Drugs Market

The Italy Diabetes Drugs Market size is estimated at USD 1.12 billion in 2024, and is expected to reach USD 1.31 billion by 2029, growing at a CAGR of 3% during the forecast period (2024-2029).

United Kingdom (UK) Diabetes Drugs Market

The United Kingdom Diabetes Drugs Market size is estimated at USD 1.06 billion in 2024, and is expected to reach USD 1.24 billion by 2029, growing at a CAGR of 3.05% during the forecast period (2024-2029).

France Diabetes Drugs Market

The France Diabetes Drugs Market size is estimated at USD 1.42 billion in 2024, and is expected to reach USD 1.67 billion by 2029, growing at a CAGR of 3.22% during the forecast period (2024-2029).

Spain Diabetes Care Drugs Market

The Spain Diabetes Care Drugs Market size is estimated at USD 1.21 billion in 2024, and is expected to reach USD 1.52 billion by 2029, growing at a CAGR of 4.5% during the forecast period (2024-2029).

Brazil Diabetes Drugs Market

The Brazil Diabetes Drugs Market size is estimated at USD 1.66 billion in 2024, and is expected to reach USD 2.02 billion by 2029, growing at a CAGR of 4.10% during the forecast period (2024-2029).

Australia Diabetes Care Drugs Market

The Australia Diabetes Care Drugs Market size is estimated at USD 815.19 million in 2024, and is expected to reach USD 972.88 million by 2029, growing at a CAGR of 3.60% during the forecast period (2024-2029).

North America Sulfonylureas Market

The North America Sulfonylureas Market size is estimated at USD 3.11 billion in 2024, and is expected to reach USD 3.41 billion by 2029, growing at a CAGR of 1.9% during the forecast period (2024-2029).

Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market

The Latin America Glucagon-like Peptide-1 Agonists Market size is estimated at USD 203.89 million in 2024, and is expected to reach USD 266.48 million by 2029, growing at a CAGR of 5.5% during the forecast period (2024-2029).

Fabry Disease Treatment Market

The Fabry disease treatment market is expected to register a CAGR of 6.8% over the forecast period.

APAC Biguanide Market

The APAC Biguanide Market size is estimated at USD 1.97 billion in 2024, and is expected to reach USD 2.17 billion by 2029, growing at a CAGR of 2% during the forecast period (2024-2029).

Latin America Biguanide Market

The Latin America Biguanide Market size is estimated at USD 386.66 million in 2024, and is expected to reach USD 443.91 million by 2029, growing at a CAGR of 2.80% during the forecast period (2024-2029).

Latin America Human Insulin Drugs Market

The Latin America Human Insulin Drugs Market size is estimated at USD 1.51 billion in 2024, and is expected to reach USD 1.75 billion by 2029, growing at a CAGR of 3.10% during the forecast period (2024-2029).

Germany Insulin Drugs And Delivery Devices Market

The Germany Insulin Drugs And Delivery Devices Market size is estimated at USD 1.10 billion in 2024, and is expected to reach USD 1.13 billion by 2029, growing at a CAGR of 0.5% during the forecast period (2024-2029).

Spain Insulin Drugs And Delivery Devices Market

The Spain Insulin Drugs and Delivery Devices Market size is estimated at USD 0.35 billion in current year, and is expected to reach USD 0.38 million by forecast year, growing at a CAGR of 1.80% during the forecast period.

Italy Insulin Drugs and Delivery Devices Market

The Italy Insulin Drugs and Delivery Devices Market size is estimated at USD 531.86 million in 2024, and is expected to reach USD 572.96 million by 2029, growing at a CAGR of 1.5% during the forecast period (2024-2029).

Russia Insulin Drugs and Delivery Devices Market

The Russia Insulin Drugs and Delivery Devices Market size is estimated at USD 1.10 billion in 2024, and is expected to reach USD 1.14 billion by 2029, growing at a CAGR of 0.58% during the forecast period (2024-2029).

Mexico Insulin Drugs And Delivery Devices Market

The Mexico Insulin Drugs And Delivery Devices Market size is estimated at USD 546.96 million in 2024, and is expected to reach USD 572.01 million by 2029, growing at a CAGR of 0.9% during the forecast period (2024-2029).

Brazil Insulin Drugs & Delivery Devices Market

The Brazil Insulin Drugs & Delivery Devices Market size is estimated at USD 937.42 million in 2024, and is expected to reach USD 990.12 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029).

Latin America Insulin Delivery Devices Market

The Latin America Insulin Delivery Devices Market size is estimated at USD 7.14 million in 2024, and is expected to reach USD 8.16 million by 2029, growing at a CAGR of greater than 2% during the forecast period (2024-2029).

Head and Neck Cancer Therapeutics Market

The Head and Neck Cancer Therapeutics Market is expected to register a CAGR of 9% over the forecast period.

Sanofi Reports - Industry Research

Reports Featuring Sanofi